Cargando…

Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease

Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2 infection and is associated with both acute and chronic disorders affecting the nervous system. Acute neurological disorders affecting patients with COVID-19 range widely from anosmia, stroke, encephalopathy/encephalitis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balcom, Erin F, Nath, Avindra, Power, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719840/ https://www.ncbi.nlm.nih.gov/pubmed/34398188 http://dx.doi.org/10.1093/brain/awab302

Ejemplares similares

Neurological issues during COVID-19: An overview
por: Nath, Avindra, et al.
Publicado: (2021)

COVID-19 and Vaccination in the Setting of Neurologic Disease: An Emerging Issue in Neurology
por: Marsh, Elisabeth B., et al.
Publicado: (2021)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19
por: Garcia-Montojo, Marta, et al.
Publicado: (2021)

Human Endogenous Retroviruses in Neurological Diseases
por: Küry, Patrick, et al.
Publicado: (2018)

Silencing of immune activation with methotrexate in patients with COVID-19
por: Safavi, Farinaz, et al.
Publicado: (2020)

COVID-19: dealing with a potential risk factor for chronic neurological disorders
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Grand Challenges in Neuroinfectious Diseases
por: Nath, Avindra
Publicado: (2017)

Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases
por: Calvier, Laurent, et al.
Publicado: (2023)

Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases
por: Cai, Junying, et al.
Publicado: (2014)

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
por: Aghagoli, Ghazal, et al.
Publicado: (2020)

Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis
por: Jaeger, Laura B., et al.
Publicado: (2012)

Neurological manifestations of Erdheim–Chester Disease
por: Boyd, Louisa C., et al.
Publicado: (2020)

Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19
por: Jesuthasan, Aaron, et al.
Publicado: (2021)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

COVID-19 and the neurological disease therapeutic pipeline
por: Jicha, Gregory A., et al.
Publicado: (2020)

Virtual visits for chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
por: Kovvuru, Sukanthi, et al.
Publicado: (2021)

Chronic neurological diseases and COVID-19: Associations and considerations
por: Meshkat, Shakila, et al.
Publicado: (2020)

Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
por: Szabo, Marcell P., et al.
Publicado: (2022)

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
por: Stefano, George B., et al.
Publicado: (2022)

COVID-19 in patients with neurological disorders
por: Onteddu, Sanjeeva Reddy, et al.
Publicado: (2020)

Implications of COVID-19 in Neurological Disorders
por: Gaddam, Satish
Publicado: (2020)

Potential complications of monkeypox
por: Billioux, B Jeanne, et al.
Publicado: (2022)

Correction to: Virtual visits for chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Patient satisfaction with televisit in chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Patient satisfaction with televisit in chronic neurologic disorders during Covid-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2023)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases
por: Pleet, Michelle L., et al.
Publicado: (2023)

Potential neurological symptoms of COVID-19
por: Wang, Hai-Yang, et al.
Publicado: (2020)

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
por: Donatti, Amanda, et al.
Publicado: (2020)

Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
por: Cortese, Irene, et al.
Publicado: (2020)

Defining causality in COVID-19 and neurological disorders
por: Ellul, Mark, et al.
Publicado: (2020)

Neurological Disorders following COVID-19 Vaccination
por: Yang, Ying, et al.
Publicado: (2023)

Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential
por: Mitra, Saikat, et al.
Publicado: (2022)

Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
por: Yang, Yu, et al.
Publicado: (2023)

Major advances in neuroinfectious diseases in the past two decades
por: Nath, Avindra, et al.
Publicado: (2022)

COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
por: Ferini-Strambi, Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fj3pae0lujg8p0dbjb3f8t69nn